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Background/aim: To determine the hematologic manifestations at the time of diagnosis of celiac disease in children and the effects of
a gluten-free diet on hematologic signs upon follow-up.
Materials and methods: The records of patients with celiac disease who received a follow up examination at the Pediatric Gastroenterology
Clinic between June 2006 and June 2013 were retrospectively examined.
Results: Ninety-one patients were included in the study. The mean age at diagnosis was 8.1 ± 4.21 years and 59 patients (64.8%) were
female. Thirty-two patients (35.2%) had hematologic signs at the time of diagnosis. Anemia (24.2%) was the most common hematologic
sign, followed by thrombocytosis (16.5%) and leukopenia (4.4%). The tTG IgA titers were screened in 80 of the 91 patients during
diagnosis. Follow-up examinations found that remission for anemia (P = 0.017), thrombocytosis (P = 0.039), and decreases in tTG IgA
titers (P = 0.034) were more prominent in patients who had followed a strict gluten-free diet.
Conclusion: Approximately one-third of the celiac disease patients had hematologic manifestations at the time of diagnosis. Remission
in hematologic signs and decrease in tTG IgA titers were more prominent in patients who had adhered to a gluten-free diet.
Key words: Anemia, celiac, leukopenia, thrombocytosis, tTG IgA

1. Introduction
Celiac disease (CD) is a chronic immune-mediated disease
that specifically affects the proximal small intestines (1).
The pathophysiology of the disease involves autoimmune
mechanisms playing a role in intestinal mucosal injuries
due to a hypersensitivity against gluten in genetically
predisposed individuals resulting in malabsorption. The
diagnosis of CD is made with the aid of a small-bowel
biopsy, which is still considered the gold standard (2,3).
Serologic testing is based on identifying immunoglobulin
A (IgA) antibodies against gliadin, endomysium, and
tissue transglutaminase. Antiendomysium antibodies
(EMAs) and antitissue transglutaminase antibodies (antitTGAs) have been shown to be highly sensitive and specific
(4–8). Anti-tTGAs are now widely used for the diagnosis
of CD and for monitoring gluten-free diet adherence. The
clinical presentation of CD is extremely heterogeneous.
Typical symptoms include chronic diarrhea, abdominal
distension, and a failure to thrive (9,10). However, patient
presentations with extraintestinal signs are becoming
* Correspondence: erdemtopal44@gmail.com

more common in CD. The hematologic system is one of
the most affected extraintestinal systems, with anemia
being the most presented sign (11). Anemia in CD is
usually due to a malabsorption of micronutrients, such as
iron, folic acid, and vitamin B12 (11). Thrombocytopenia,
thrombocytosis, neutropenia, and a predisposition to
thrombosis are also observed (11). Gluten-free diets, the
main treatment of the disease, reduce ailments, prevent
complications, and also improve hematologic signs. This
study was aimed to determine the hematologic signs of
CD at the time of diagnosis and to examine the effects of a
gluten-free diet on hematologic signs and tTG IgA titers.
2. Materials and methods
The records of patients with a CD diagnosis, who were
followed up in the Pediatric Gastroenterology Clinic
between June 2006 and June 2013, were investigated
retrospectively. Therefore, this study is a retrospective
chart review study. The patients’ demographic features,
complaints at presentation, celiac disease serology (tTG
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IgA and EMA IgA), duodenal biopsy findings according
to Marsh classification, complete blood count results at
diagnosis, treatment provided, diet adherence, period of
follow-up, complete blood count results at the last visit,
and whether or not the patient came for regular checkups
were noted for each patient. The diagnosis of celiac
disease was done according to the European Society for
Pediatric Gastroenterology, Hepatology, and Nutrition
(ESPGHAN) guidelines (12) in our clinic. The serologic
screening included tTGA IgA and EMA IgA. Serum tTGA
IgA values were measured using the ELiA Celikey IgA kit
(Phadia AB, Uppsala, Sweden). As recommended by the
manufacturer, serum samples containing an antibody titer
greater than 10 U/mL were considered positive. IgA EMA
values were detected by indirect immunofluorescence
using sections of distal monkey esophagus mounted on
glass slides (EUROIMMUN, Lübeck, Germany). The
histological examinations of biopsy specimens were
performed by an experienced pathologist using the
Marsh classification as modified by Oberhuber (3,14).
According to this classification, an increased number of
intraepithelial lymphocytes (Marsh I) were considered not
to be diagnostic for CD. In contrast, Marsh I combined
with crypt hyperplasia (Marsh II) or findings with villous
atrophy (Marsh III) were considered to be diagnostic
for CD. All the patients were given a gluten-free diet for
their treatment and were required to come for a regular
checkup at 3-month intervals. Anti‑tTGA IgA antibodies
were screened to evaluate the patients at diagnosis and
to monitor their adherence to the diet. Patients with
hemoglobin values of less than 10.5 mg/dL in those
younger than 6 years old, 11 mg/dL in those 6–11 years of
age, 12 mg/dL in females older than 12 years of age, and 13
mg/dL in males older than 12 years of age were considered
anemic (15). Iron deficiency anemia was defined as
microcytic anemia with a low mean corpuscular volume
and a high red cell distribution width (16). Leukopenia was
defined as a white blood cell counts of less than 4000 mm3
in the complete blood count and neutropenia as an absolute
neutrophil count of less than 1500 mm3. Thrombocytosis
(17) was defined as a platelet count of more than 450 × 106.
Patients with obvious blood loss, such as those with a
history of melena, hematochezia, hemoptysis, recurrent
epistaxis, hematuria, and trauma; those with chronic
diseases (e.g., chronic liver disease, chronic renal failure,
heart failure, etc.) or hematologic diseases; and those with
IgA deficiency were excluded from the study.
This study was approved by the Ethics Committee
of the Turgut Özal Medical Center of İnönü University
(approval number 101 /2013).
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3. Results
3.1. Demographic features
Ninety-one patients with celiac disease as indicated by
duodenal biopsy, and who met the study criteria, were
included in the study. Fifty-nine (64.8%) patients were
girls and the mean age at diagnosis for all patients was 8.1
± 4.21 years. The median follow-up time of the patients
after diagnosis was 48 months, varying between 12
months and 84 months. The patients mostly presented
with gastrointestinal complaints. Abdominal pain was
the most common complaint among the gastrointestinal
symptoms (Table 1). Seven (7.7%) of the patients had
diabetes mellitus, five (5.5%) had gastritis, and one (1.1%)
had gallstones at the same time. At diagnosis, of the 91
patients, 80 had their tTG IgA titers screened and 35
had their EMA IgA antibodies screened. While all of the
80 patients who had their tTG IgA titers screened were
positive, 20 (57.1%) of the 35 patients who had their EMA
IgA antibodies screened were found to be positive. Ten
patients (12.5%) had tTG IgA levels of <100 U/mL and
70 patients (87.5%) had tTG IgA levels of ≥100 U/mL. In
the histopathologic examination of the duodenal biopsy
specimen, six (6.6%) of the patients who were screened for
tTG IgA had a Marsh II lesion and 85 patients (93.4%) had
a Marsh III lesion. Sixty-eight (97.1%) of the patients who
had tTG IgA levels of ≥100 U/mL had Marsh III lesions
in the pathologic examination of the biopsy specimen.
Despite all the patients being advised to follow a glutenfree diet, only 52 (57.1%) of them adhered to the treatment
completely and 34 (37.4%) returned for a regular checkup.
During the follow-up examination, the last tTG IgA
titers were significantly lower in patients who adhered
completely to the gluten-free diet compared to those who
did not adhere completely to the diet (P = 0.034) (Table 2).
Table 1. Symptoms of patients with celiac disease at the time of
diagnosis (n = 91).
Symptoms and signs

n (%)

Gastrointestinal system symptoms/signs
Abdominal pain
Diarrhea
Anorexia
Abdominal distention
Constipation
Vomiting
Extraintestinal signs/symptoms
Failure to thrive
Arthralgia
Asymptomatic

67 (73.6)
57 (62.6)
17 (18.7)
16 (17.6)
13 (14.3)
9 (9.9)
6 (6.6)
52 (57.1)
1 (1)
4 (4.4)
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Table 2. The effect of strict gluten-free diet on the hematologic manifestation and tTG Ig A* antibody.

Variable
Hematologic manifestation
Anemia
Microcytic
Normocytic
Leukopenia
Neutropenia
Thrombocytosis
Celiac serology
tTG Ig A antibody, median (min-max)

At the time of
diagnosis n (%)

After gluten-free diet
Did not adhere to
gluten-free diet n (%)

Adhered to
gluten-free diet n (%)

22 (24.2)
22
4 (4.4)
3 (3.3)
15 (16.5)

10/39 (25.6)
10
6/39 (15.4)

3/52 (5.8)
3
1/52 (3.8)

0.017

207 (15–300)

20.8 (0–300)

8.1 (0–146)

0.034

P-value

0.039

*tTG IgA: tissue transglutaminase IgA.

3.2. Hematologic manifestations at the time of diagnosis
and the effect of a gluten-free diet on the hematologic
parameters
Thirty-two (35.2%) of the CD patients had hematologic
manifestations at the time of diagnosis, with anemia being
the most commonly presented hematologic sign (24.2%).
All of the anemic patients had microcytic anemia due to
iron deficiency. All of the patients were given a gluten-free
diet to follow and those with anemia were also given iron
treatment. The last screened complete blood count was also
examined from the patients’ records. Anemia persisted in
13 patients (14.3%) and thrombocytosis persisted in seven
patients (7.7%). When remission of hematologic signs was
compared in patients who maintained a strict gluten-free
diet versus those who did not, anemia (P = 0.017) and
thrombocytosis (P = 0.039) were less persistent in patients
who had adhered completely to the diet (Table 2).
4. Discussion
Our study showed that one-third of CD patients of
childhood age had hematologic manifestations at the
time of diagnosis, and microcytic anemia was the most
commonly presented hematologic sign, followed by
thrombocytosis and leukopenia. Moreover, all of our
patients had positive tTG IgA at the time of diagnosis. An
improvement in hematologic signs and a definite decrease
in tTG IgA titer levels were observed in patients who
adhered to a strict gluten-free diet.
Hematologic manifestations are one of the most
presented extraintestinal signs of CD. Anemia is the most
common hematologic sign with a prevalence varying
between 12% and 69% (18–22). Deficiencies in iron,
vitamin B12, and other microelements are thought to play
a role in the etiology of anemia (11,23). At the same time,

anemia could occur as a result of the chronic inflammation
that occurs with CD (24). Anemia was the most common
hematologic sign in our study, being present in one-fourth
of the patients. All those with anemia were microcytic and
linked to an iron deficiency. Only 5.8% of patients with
strict gluten-free diet adherence had anemia persisting at
follow-up.
Thrombocytopenia rarely develops in CD and is
generally a result of autoimmune mechanisms (25–
27). Thrombocytosis is more commonly seen than
thrombocytopenia with a prevalence of up to 60% in CD
patients (11,28,29). Even though its etiology is not well
known, it is thought to be due to inflammatory mediators,
iron deficiency anemia, or functional hyposplenism.
Thrombocytosis has been shown to improve with a
gluten-free diet (28). In our study, 16.5% of patients had
thrombocytosis at the time of diagnosis; however, only
3.8% of patients who adhered to a gluten-free diet had
persisting thrombocytosis at follow up.
Leukopenia has been reported in some CD patients
(25) and is thought to be due to folic acid and copper
deficiencies. Therefore, it is advised that patients with
leukopenia who have folic acid or copper deficiencies be
supplemented with these minerals. Leukopenia was the
least commonly seen hematologic sign in our study and
folic acid levels were normal in those patients. Leukopenia
was improved in all patients after following a gluten-free
diet.
The only treatment for CD is a lifelong exclusion of
gluten. This requires a wheat-, barley-, and rye-free diet.
After gluten withdrawal, there is a rapid remission of
symptoms, improved bone mineralization, and reversal
of growth failure and nutritional deficiencies. After the
diagnosis of CD, children with CD should be monitored
with periodic assessments of symptoms, growth,

665

ÇATAL et al. / Turk J Med Sci
physical examinations, and adherence to a gluten-free
diet. Measuring tTGA titers after a gluten-free diet can
be helpful in evaluating adherence to the diet. Gluten
withdrawal leads to a reduction of tTGA titers (15). In our
study, patients who strictly adhered to a gluten‑free diet
had improved hematologic signs and a reduction in tTG
IgA levels that were more evident compared to patients
without strict adherence to a gluten-free diet.
The retrospective nature of our study is the main
limitation that might affect our results due to a lack of data

for some parameters, such as tTGA (in one of the nine
cases) and EMA (in one-third of the cases).
In conclusion, approximately one-third of our patients
had hematologic involvement signs at diagnosis, with
anemia being the most and leukopenia the least commonly
presented sign. Almost all of the patients had tTGA titers
of over 100 U/mL. Improvements in hematologic signs
and decreases in tTGA titers were evident in patients who
strictly adhered to a gluten-free diet.
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